A Cyclometalated Ruthenium(II) Complex Induces Oncosis for Synergistic Activation of Innate and Adaptive Immunity
Angewandte Chemie International Edition · 29.07.2024 · 63 (31)
DOI: 10.1002/anie.202405679 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 30.06.2024. Verfasst von Tao Feng und 8 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, State Key Laboratory of Anti-Infective Drug Discovery and Development, Guangdong Basic Re…. Hauptthemen laut MEDLINE: Adaptive Immunity, Immunity, Innate, Ruthenium, Coordination Complexes. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: the National Natural Science Foundation of China, the Science and Technology Innovation Program of Hunan Province of China.
Abstract (Originalsprache)
An optimal cancer chemotherapy regimen should effectively address the drug resistance of tumors while eliciting antitumor‐immune responses. Research has shown that non‐apoptotic cell death, such as pyroptosis and ferroptosis, can enhance the immune response. Despite this, there has been limited investigation and reporting on the mechanisms of oncosis and its correlation with immune response. Herein, we designed and synthesized a Ru(II) complex that targeted the nucleus and mitochondria to induce cell oncosis. Briefly, the Ru(II) complex disrupts the nucleus and mitochondria DNA, which active polyADP‐ribose polymerase 1, accompanied by ATP consumption and porimin activation. Concurrently, mitochondrial damage and endoplasmic reticulum stress result in the release of Ca 2+ ions and increased expression of Calpain 1. Subsequently, specific pore proteins porimin and Calpain 1 promote cristae destruction or vacuolation, ultimately leading to cell membrane rupture. The analysis of RNA sequencing demonstrates that the Ru(II) complex can initiate the oncosis‐associated pathway and activate both innate and adaptive immunity. In vivo experiments have confirmed that oncosis promotes dendritic cell maturation and awakens adaptive cytotoxic T lymphocytes but also activates the innate immune by inducing the polarization of macrophages towards an M1 phenotype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, State Key Laboratory of Anti-Infective Drug Discovery and Development, Guangdong Basic Research Center of Excellence for Functional Molecular Engineering, Scho…
- MOE Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, 400201, P. R. China.
ORCID-Profile: Hui Chao
Förderung
- the National Natural Science Foundation of China
- the Science and Technology Innovation Program of Hunan Province of China
Zitieren
APA
Feng, T., Tang, Z., Shu, J., Wu, X., Jiang, H., Chen, Z., Chen, Y., Ji, L., & Chao, H. (2024). A Cyclometalated Ruthenium(II) Complex Induces Oncosis for Synergistic Activation of Innate and Adaptive Immunity. Angewandte Chemie International Edition, 63(31). https://doi.org/10.1002/anie.202405679
Vancouver
Feng T, Tang Z, Shu J, Wu X, Jiang H, Chen Z, et al. A Cyclometalated Ruthenium(II) Complex Induces Oncosis for Synergistic Activation of Innate and Adaptive Immunity. Angewandte Chemie International Edition. 2024;63(31). doi:10.1002/anie.202405679
BibTeX
@article{Feng2024,
author = {Feng, Tao and Tang, Zixin and Shu, Jun and Wu, Xianbo and Jiang, Hui and Chen, Zhuoli and Chen, Yu and Ji, Liangnian and Chao, Hui},
title = {A Cyclometalated Ruthenium(II) Complex Induces Oncosis for Synergistic Activation of Innate and Adaptive Immunity},
journal = {Angewandte Chemie International Edition},
year = {2024},
volume = {63},
number = {31},
doi = {10.1002/anie.202405679}
}
EUVIMED